Skip to main content
Erschienen in: Metabolic Brain Disease 2/2013

01.06.2013 | Original Paper

Psychometric tests for diagnosing minimal hepatic encephalopathy

verfasst von: Karin Weissenborn

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

While it is consensus that minimal hepatic encephalopathy (mHE) has significant impact on a patient’s daily living, and thus should be diagnosed and treated, there is no consensus about the optimal diagnostic tools. At present the most frequently used psychometric methods for diagnosing minimal hepatic encephalopathy are the Inhibitory Control Test and the Psychometric Hepatic Encephalopathy Score PHES. Another frequently used method is Critical Flicker Frequency. The PHES and the Repeatable Battery for the Assessment of Neuropsychological Status have been recommended for diagnosing mHE by a working party commissioned by the International Society for Hepatic Encephalopathy and Nitrogen Metabolism. Recently the Continuous Reaction Time Test, which has been used in the 1980ies, has gained new interest. Today, no data are available that allow to decide which of these methods is the most appropriate. In fact, even basic information such as dependence on age, sex and education or influence of diseases that frequently accompany liver cirrhosis upon test results is missing for most of them. Future studies must address these questions to improve diagnosis of mHE.
Literatur
Zurück zum Zitat Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19(3–4):253–67PubMedCrossRef Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19(3–4):253–67PubMedCrossRef
Zurück zum Zitat Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010) Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 139(2):510–518PubMedCrossRef Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010) Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 139(2):510–518PubMedCrossRef
Zurück zum Zitat Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM (2007) Inhibitory Control Test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102:754–760PubMedCrossRef Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM (2007) Inhibitory Control Test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102:754–760PubMedCrossRef
Zurück zum Zitat Elsass P, Christensen SE, Ranek L, Theilgaard A, Tygstrup N (1981) Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroent 16:441–447PubMedCrossRef Elsass P, Christensen SE, Ranek L, Theilgaard A, Tygstrup N (1981) Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroent 16:441–447PubMedCrossRef
Zurück zum Zitat Elsass P, Christensen SE, Jorgensen F, Mortensen EL, Vilstrup H (1984) Number connection test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study. Acta pharmacol et toxicol 54:115–119CrossRef Elsass P, Christensen SE, Jorgensen F, Mortensen EL, Vilstrup H (1984) Number connection test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study. Acta pharmacol et toxicol 54:115–119CrossRef
Zurück zum Zitat Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357–366PubMedCrossRef Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357–366PubMedCrossRef
Zurück zum Zitat Lauridsen MM, Jepsen P, Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2):135–139PubMedCrossRef Lauridsen MM, Jepsen P, Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2):135–139PubMedCrossRef
Zurück zum Zitat Lauridsen MM, Grønbæk H, Næser EB, Leth ST, Vilstrup H (2012) Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis [Epub ahead of print]. doi:10.1007/s11011-012-9318-6 Lauridsen MM, Grønbæk H, Næser EB, Leth ST, Vilstrup H (2012) Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis [Epub ahead of print]. doi:10.​1007/​s11011-012-9318-6
Zurück zum Zitat Lockwood AH (2000) What's in a name? Improving the care of cirrhotics. J Hepatol 32(5):859–861PubMedCrossRef Lockwood AH (2000) What's in a name? Improving the care of cirrhotics. J Hepatol 32(5):859–861PubMedCrossRef
Zurück zum Zitat Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W (2002) Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 17(1):29–40PubMedCrossRef Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W (2002) Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 17(1):29–40PubMedCrossRef
Zurück zum Zitat Randolph C (1998) The repeatable battery for the assessment of neuropsychological status (RBANS). The Psychological Corporation, San Antonio Randolph C (1998) The repeatable battery for the assessment of neuropsychological status (RBANS). The Psychological Corporation, San Antonio
Zurück zum Zitat Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN), International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) (2009) Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Internat 29(5):629–635CrossRef Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN), International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) (2009) Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Internat 29(5):629–635CrossRef
Zurück zum Zitat Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13(4):361–377PubMedCrossRef Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13(4):361–377PubMedCrossRef
Zurück zum Zitat Smith JM, Misiak H (1976) Critical Flicker Frequency (CFF) and psychotropic drugs in normal human subjects—a review. Psychopharmacology 47:175–182CrossRef Smith JM, Misiak H (1976) Critical Flicker Frequency (CFF) and psychotropic drugs in normal human subjects—a review. Psychopharmacology 47:175–182CrossRef
Zurück zum Zitat Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773PubMedCrossRef Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773PubMedCrossRef
Metadaten
Titel
Psychometric tests for diagnosing minimal hepatic encephalopathy
verfasst von
Karin Weissenborn
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 2/2013
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-012-9336-4

Weitere Artikel der Ausgabe 2/2013

Metabolic Brain Disease 2/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.